Harold Davidson & Associates Inc.
Position in ALLO — Allogene Therapeutics, Inc.
CIK 1430022
Los Angeles, CA
Position in ALLO
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$585,565
-$120,136 QoQ
Shares Held
281,522
-2.7% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#4
of 32 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Harold Davidson & Associates Inc. holds $585,565 across 1 Biotechnology name. ALLO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALLO |
Allogene Therapeutics, Inc.
This page
|
281,522 | $585,565 |
All Filings in ALLO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $585,565 | 281,522 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $705,701 | 289,222 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $266,811 | 194,753 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $366,335 | 295,432 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $152,807 | 135,228 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $368,431 | 252,350 | Shares | Sole | 2025-06-04 | |
| 2024-12-31 | $495,469 | 232,615 | Shares | Sole | 2025-06-04 | |
| No filing history on record for this holder in this stock. | ||||||